Valuation : ResMed, Inc.

Market Cap 3.47TCr 2.98TCr 2.8TCr 2.56TCr 4.81TCr 3,29900Cr 4.84TCr 33TCr 13TCr 1,67300Cr 13TCr 13TCr 5,53800Cr P/E 2027 *
20.9x
P/E 2028 * 18.8x
Enterprise Value 3.37TCr 2.9TCr 2.73TCr 2.49TCr 4.67TCr 3,20900Cr 4.71TCr 32TCr 13TCr 1,62700Cr 13TCr 12TCr 5,38700Cr EV / Sales 2027 *
5.8x
EV / Sales 2028 * 5.32x
Free-Float
75.13%
Yield 2027 *
1.11%
Yield 2028 * 1.22%
1 day-0.18%
1 week+3.25%
Current month+13.76%
1 month+13.76%
3 months+28.73%
6 months-7.08%
Current year-0.36%
1 week 231.88
Extreme 231.885
241.71
1 month 202
Extreme 202
241.71
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
284.87
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Exercice

Chief Executive Officer

14,973 0.0103%
05/08/26 Sell

Founder

-8,000 0.0055%
07/07/26 Exercice

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%+3.25%-11.43%+50.39% 3.47TCr
-0.80%-2.05%+26.32%+10.54% 23TCr
-0.99%-0.39%+5.14%-19.14% 15TCr
+0.63%+0.26%-20.15%+19.78% 13TCr
+2.73%-1.84%-54.89%-10.81% 6.79TCr
+0.95%+0.45%+11.18%+18.88% 5.2TCr
-0.99%-3.12%-17.97%-15.39% 5.1TCr
-0.48%-0.55%+21.86%+26.03% 4.34TCr
-0.50%+0.39%+39.08%+46.85% 4.07TCr
-1.61%-4.79%+117.26%+28.63% 3.26TCr
Average -0.12%-1.25%+11.64%+15.58% 8.36TCr
Weighted average by Cap. -0.20%-1.47%+7.28%+8.73%

Financials

2027 *2028 *
Net sales 581.81Cr 500.94Cr 470.36Cr 429.36Cr 806.6Cr 55TCr 812.38Cr 5.57TCr 2.17TCr 28TCr 2.18TCr 2.14TCr 93TCr 619.85Cr 533.69Cr 501.12Cr 457.44Cr 859.34Cr 59TCr 865.5Cr 5.94TCr 2.31TCr 30TCr 2.33TCr 2.28TCr 99TCr
Net income 162.86Cr 140.22Cr 131.66Cr 120.18Cr 225.78Cr 15TCr 227.4Cr 1.56TCr 607.01Cr 7.86TCr 611.47Cr 598.19Cr 26TCr 178.22Cr 153.45Cr 144.08Cr 131.52Cr 247.08Cr 17TCr 248.85Cr 1.71TCr 664.28Cr 8.6TCr 669.16Cr 654.62Cr 28TCr
Net Debt -95Cr -82Cr -77Cr -70Cr -131.33Cr -9.01TCr -132.27Cr -907.47Cr -353.07Cr -4.57TCr -355.67Cr -347.94Cr -15TCr -168.64Cr -145.2Cr -136.33Cr -124.45Cr -233.79Cr -16TCr -235.47Cr -1.62TCr -628.56Cr -8.14TCr -633.18Cr -619.42Cr -27TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
11,370
Date Price Change Volume
01/26/01 $239.85 -0.20% 6,93,692
28/26/28 $240.33 +1.94% 13,86,748
27/26/27 $235.76 +0.03% 15,88,523
26/26/26 $235.69 -0.38% 15,42,343
25/26/25 $236.59 +1.78% 17,61,110
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
240.33USD
Average target price
246.25USD
Spread / Average Target
+2.46%

Quarterly revenue - Rate of surprise